U.S. Biotech Stock News

Why this governance push at Nexstar Media Group (NXST) matters for shareholders The Communications Workers of America has moved to rally Nexstar Media Group investors behind five governance changes, including proxy access, easier special meeting rights, poison pill oversight, an independent chair, and tighter approval rules for large deals. See our latest analysis for Nexstar Media Group. At a share price of $236.52, Nexstar has a 90 day share price return of 16.78% and a 1 year total...

Ameresco (NYSE:AMRC) has completed a comprehensive Energy Performance Contract for Charlo School District in Montana. The company has also finished a large residential energy upgrade at the Fort Polk U.S. Army base. Projects include high efficiency heat pumps, geothermal infrastructure, and other modernization work across education and military housing. These initiatives use grants and public private partnerships to support infrastructure improvements, operational savings, and sustainability...

Recent share performance and what it might mean for investors Hercules Capital (HTGC) has drawn attention after a period of weaker share performance, with the stock showing a 0.1% gain over the past day but declines over the past week, month, and past 3 months. For income and value focused investors watching business development companies, the recent volatility around Hercules Capital may prompt a closer look at how its lending focused model and current valuation metrics align with individual...

Lowe's Companies (NYSE:LOW) has partnered with Affirm to introduce buy now, pay later options for customers. The new flexible payment choices are available on Lowe's website and mobile app. Lowe's will also appear on Affirm's marketplace, giving the retailer additional exposure to potential shoppers. Lowe's enters this update with a share price of $242.11 and a mixed recent return profile, with the stock up 9.4% over the past year and 30.5% over three years, but showing a 15.8% decline over...

How Albertsons Companies Stock Has Been Trading Recently Albertsons Companies (ACI) has seen a mixed stretch recently, with a modest move over the past week, softer performance over the month, and a slight decline across the past 3 months. See our latest analysis for Albertsons Companies. At a share price of $17.31, Albertsons Companies has seen recent share price pressure, with a 30 day share price return decline of 6.79%, while the 1 year total shareholder return decline of 18.61% contrasts...

NeoGenomics (NEO) has drawn attention after its share price closed at $8.24, with recent returns showing pressure over the past month and past 3 months, prompting investors to reassess the cancer testing specialist. See our latest analysis for NeoGenomics. The recent 1 day share price return of 4.57% comes after a 30 day share price decline of 27.59% and a 1 year total shareholder return of 16.26% in the red. This indicates that pressure has been building for some time rather than momentum...

ExxonMobil (NYSE:XOM) partnered with Halliburton and other firms to complete what is reported as the world’s first fully automated geological well placement in offshore Guyana. The project integrated advanced drilling automation, real time subsurface interpretation, and automated rig operations within a single system. This alliance is described as a new benchmark for well construction efficiency and reservoir contact in ExxonMobil's core upstream region of Guyana. For investors tracking...

In recent days, Chevron and other major oil executives warned the Trump administration that disruptions around the Strait of Hormuz and the Iran war are worsening global energy supply risks and fueling heightened oil market volatility. At the same time, Chevron’s role as a large, long-tenured dividend payer and its efforts to diversify supply outside the Gulf, including Venezuela talks, underscore how geopolitics and capital allocation are increasingly intertwined for the company. We’ll now...

European publishers, technology firms, and startups are urging the European Commission to swiftly conclude a nearly two-year antitrust probe into Google's search practices. The groups are calling for a fine and a formal decision under the EU Digital Markets Act related to alleged self-preferencing in Alphabet's search results. For investors watching Alphabet, ticker NasdaqGS:GOOGL, this push adds another layer to the regulatory attention already surrounding its core search business...

In early March 2026, Signet Jewelers presented at three major consumer and retail conferences hosted by Citi, Bank of America, and UBS in Florida and New York, sharing updates with institutional investors. These appearances came as the jeweler flagged pressure from higher gold and silver costs and slightly weaker same-store sales toward late 2025, prompting more cautious sentiment around its outlook. We’ll now explore how rising precious metal costs and softer same-store sales readings may...

Wondering if QUALCOMM at around US$129 per share still offers value, or if the easy gains are already gone, starts with understanding what the recent share price is really telling you. The stock is around US$129.39 after a 6.3% decline over the last week, an 8.0% decline over the last month and a 25.2% decline year to date, while the 1 year return sits at a 16.2% loss versus positive 3 and 5 year returns of 13.7% and 7.6% respectively. These shorter term pullbacks sit against a backdrop of...

Earlier in March 2026, Amazon.com, Inc. completed a record multi-currency bond sale, issuing around US$37 billion and several billion euros of senior unsecured notes across maturities ranging from 2028 to 2076 to help finance large-scale AI and cloud data center infrastructure. The size and breadth of this debt issuance, supported by a broad syndicate of global underwriters, underline how central long-term AI and AWS capacity build-out has become to Amazon’s corporate funding strategy. We’ll...

Expedia Group recently reported a strong finish to 2025, with top- and bottom-line results exceeding expectations and management issuing more optimistic guidance. Investor sentiment has also improved as OpenAI decided not to enable direct travel bookings in ChatGPT, easing worries about AI disrupting Expedia’s online travel agency model while still allowing the company to participate in AI-driven travel discovery. Next, we’ll examine how easing AI disruption concerns, combined with Expedia’s...

In recent days, Moody's Corporation drew attention by issuing a negative credit outlook for New York City and being caught in broader market concerns after JPMorgan Chase restricted lending to private credit providers, even as Moody's also featured in a new climate‑focused REIT ETF that uses its physical risk models. This mix of heightened municipal and private credit risk concerns alongside the application of Moody's climate analytics to a new ETF underscores how the company sits at the...

New value menu push and what it could mean for McDonald's (MCD) stock McDonald's (MCD) is leaning into lower price points, with new menu items at $3 or less and $4 breakfast deals set to launch across the U.S. starting in April. The company is targeting budget conscious diners at a time of economic pressure and tighter restaurant spending, using bundled value offers to support traffic while defending its brand position with cost sensitive households. See our latest analysis for McDonald's. At...

Ford Motor stock snapshot Ford Motor (F) has drawn investor attention after recent share weakness, with the stock showing negative returns over the past week, month, and past 3 months while still carrying a positive 1 year total return. See our latest analysis for Ford Motor. Recent share price momentum has faded, with a 30 day share price return of 17.07% and a 90 day share price return of 14.34%, while the 1 year total shareholder return of 24.11% remains positive. If Ford's recent pullback...

Veracyte, Inc. recently appointed Kevin Haas, Ph.D., as its first Chief Development and Technology Officer, tasking him with overseeing end-to-end product development across diagnostic assays, software, bioinformatics and program management to support its expanding global portfolio of laboratory-developed tests and in vitro diagnostic products. This new role, filled by a leader with deep experience in automated lab technology, AI and genomics platforms, underscores Veracyte’s intent to more...

Tenaya partnership broadens Alnylam’s reach into cardiovascular research The new collaboration between Alnylam Pharmaceuticals (ALNY) and Tenaya Therapeutics gives Alnylam access to up to 15 cardiovascular gene targets. Tenaya will handle early validation, while Alnylam will fund and lead downstream drug development. Tenaya is set to receive up to US$10 million upfront plus cost reimbursement over a two-year validation period. The company may also earn as much as US$1.13 billion in...

Institutional exit and insider sales draw attention to CMS Energy (CMS) Recent filings show Capital International Investors cut its CMS Energy (CMS) stake by 97.4%, alongside increased insider selling by executives, drawing fresh attention to ownership trends around the Michigan based utility. See our latest analysis for CMS Energy. At a share price of US$78.27, CMS Energy has delivered an 11.2% year to date share price return and a 10.1% 1 year total shareholder return. The 3 year total...

Earlier this month, Averna announced it had partnered with Curtiss-Wright to build five custom aerospace test systems that integrate secure data management and Curtiss-Wright's manufacturing execution systems for precision, safety-critical applications. This collaboration highlights how Curtiss-Wright is leaning on specialist automation expertise to enhance its production capabilities for Tier 1 aerospace programs and demanding defense customers. Next, we'll examine how this new aerospace...

In the past quarter, Hubbell reported fourth-quarter 2025 results with adjusted EPS of $4.73 and a 12% revenue increase, supported by strong data center and utility demand. Management’s emphasis on grid modernization, electrification, and a long record of growing dividends highlights how Hubbell is aligning operations with long-term infrastructure trends while reinforcing income appeal. Now we’ll examine how Hubbell’s earnings beat and upbeat 2026 growth guidance may influence its existing...

In early March 2026, Griffon Corporation reported its first-quarter fiscal 2026 results and again lowered its earnings outlook, citing a cooling housing market and tougher comparisons to prior high-growth periods. This repeated guidance cut highlights how sensitive Griffon’s performance is to housing-related demand, potentially testing earlier expectations for margin improvement and earnings expansion. We’ll now examine how this renewed earnings downgrade, set against cooling housing...

In recent days, The Times’ publication of extracts that prompted a high-profile response from the Duke and Duchess of Sussex concentrated reader attention on royal coverage, while Google faced renewed calls from European publishers including News Corp for EU regulators to conclude a long-running antitrust probe and impose penalties. Together, this surge in engagement around royal news and News Corp’s prominent role in pushing EU scrutiny of Google underscores how its UK media reach and...

Earlier in March 2026, Illumina announced a collaboration with Veritas Genetics Powered By Fuze Health to integrate whole-genome sequencing into preventive healthcare via insurance plans, while also advancing a large-scale multiomic drug discovery effort through its expanded Alliance for Genomic Discovery with Nashville Biosciences and new pharma partners. Together, these initiatives aim to make clinical-grade genomics and proteomics part of routine care and research, creating a large,...